National Cancer Control Plan 2030

Objectives

The Pandemic Plan of the Czech Republic provides a national, multisectoral framework for preparing for, responding to and recovering from influenza pandemics and comparable emerging infectious disease emergencies. It aims to reduce deaths, morbidity and wider social and economic disruption while preserving essential public services and restoring normal societal functioning after a pandemic.[1][2][3][4]

• Strengthen preparedness at national, regional and local levels by integrating pandemic arrangements into crisis-management and crisis-preparedness plans and maintaining flexible plans for uncertain scenarios.[5][6][7]
• Detect novel influenza viruses, unusual clusters of respiratory illness and related deaths early; characterise threats rapidly; and report and respond to suspected or confirmed cases.[8][9][10]
• Prevent, contain or delay transmission through surveillance, infection prevention, personal hygiene, voluntary isolation, contact tracing, social-hygiene measures, vaccination and antiviral treatment.[11][12][13]
• Mitigate health and societal consequences when containment is no longer feasible, including by maintaining healthcare capacity, protecting health workers and sustaining essential services.[14][15][16]
• Protect groups at heightened risk of severe complications, including pregnant women, young children, older people, significantly overweight people and immunocompromised patients.[17][18]
• Apply equality, benefit and efficacy, freedom, reciprocity and solidarity to balance individual and community interests, protect human rights and address the needs of vulnerable and minority groups.[5]
• Maintain clear, credible and timely communication with the public, professionals, media, families and communities to improve awareness, support protective behaviour and prevent panic and misinformation.[1][5][19]
• Prepare for the pandemic cycle before the first wave, during the main wave, after the peak and in the post-pandemic period, including readiness for a subsequent wave and recovery of healthcare, social systems and the economy.[3][4][20]

Implementation

Implementation uses a whole-of-society model in which the Government coordinates cross-sector decisions and each ministry, region and responsible organisation delivers measures within its jurisdiction through departmental and territorial pandemic plans.[1][21][22]National action is aligned with the World Health Organization, European Commission, European Centre for Disease Prevention and Control, International Health Regulations (2005) and European Union reporting and preparedness arrangements.[1][11][15]

• Coordinate national preparedness and response through the Central Epidemiology Commission, a Czech Government working body that informs the Government, coordinates regional commissions, assesses epidemiological developments and recommends nationwide anti-epidemic measures.[8]
• Establish regional epidemiology commissions through regional council presidents and convene specialist teams as required, including a multisectoral expert team from phase 3.[8][9]
• Differentiate preparedness and response according to pandemic phases and whether Czechia is affected, shifting from early detection and containment to mitigation as sustained transmission expands.[14][4][10]
• Maintain year-round clinical, virological and epidemiological influenza surveillance, supported by cooperation between healthcare and veterinary sectors, regional sample submission and reference-laboratory diagnosis.[11][9][23]
• Report national surveillance data to the European Centre for Disease Prevention and Control through The European Surveillance System and to the World Health Organization through FLU-NET; share urgent case information through the International Health Regulations and Early Warning and Response System.[11][9]
• Strengthen laboratory capacity, safe specimen collection and transport, diagnostic analysis, isolate sharing and monitoring of antiviral resistance in human and animal influenza viruses.[9][12][13]
• Prepare healthcare services for increased demand by developing clinical protocols, ensuring rapid diagnosis and treatment, arranging hospital referral for severe or high-risk cases, protecting health workers and expanding alternative care arrangements where necessary.[24][25][16]
• Deploy antivirals according to product requirements and prepare pandemic vaccination after identification of a novel subtype and World Health Organization selection of the vaccine strain; production may require at least three months and more probably six months.[24][11]
• Maintain continuity plans for energy, water, food and agriculture, transport, communications, information systems, financial services, emergency and social services, public administration, security, foreign policy, healthcare and education.[21][26][27]
• Plan protective equipment, antivirals, vaccines, medical supplies, workforce mobilisation and resource allocation for essential-service employees and selected patient groups.[7][27][28]
• Engage civilian organisations, community associations, volunteers, local authorities, non-governmental organisations and households in information sharing, service provision and support for home care.[5][26][29]
• Conduct regular coordination meetings and preparedness exercises, test communication arrangements at least annually, and revise pandemic plans at least every two years or sooner when evidence, exercises or real events require it.[7][25][30]
• Restore essential services after the peak, replenish medicines and equipment, support staff recovery, continue vaccination according to priorities and revise plans, protocols, stocks and communication strategies using lessons learnt.[20][29]

Monitoring & Evaluation

The plan establishes a comprehensive monitoring and evaluation system centred on clinical, virological and epidemiological surveillance, rapid case detection, assessment of transmission and pandemic impacts, and adjustment of measures as evidence evolves.[10][31][16]It combines national information systems and laboratory networks with reporting to European and global partners.[11][9]

• Conduct year-round surveillance of influenza and influenza-like illness, including weekly monitoring of morbidity during the usual seasonal period from calendar week 40 to week 18 of the following year.[11]
• Monitor circulating respiratory viruses through regional sample submission to the National Reference Laboratory for Influenza, generally from calendar week 40 to week 20, and track acute respiratory infections and influenza-like illness to assess morbidity trends.[32]
• Detect and investigate unusual clusters of respiratory illness or deaths, assess possible human-to-human transmission, identify animal influenza infections and sources of human infection, and investigate atypical cases and higher-risk groups.[9][31]
• Strengthen laboratory surveillance and diagnostic capacity for human and animal influenza, including the characterisation and sharing of isolates for diagnostic reagents, candidate vaccine viruses and antiviral-resistance monitoring.[9]
• Use clinical, virological and epidemiological data to monitor morbidity, mortality, geographic spread, disease characteristics, antigenic and genetic changes, pathogenicity and antiviral sensitivity.[10]
• Track resource pressures, including medicines, antivirals, vaccines, healthcare workers, hospital-bed occupancy, laboratory materials, alternative-care facilities and funeral-service capacity.[10]
• Assess pandemic planning assumptions through clinical attack rates, deaths, outpatient demand, hospitalisations, intensive-care and ventilation requirements, and workforce absenteeism.[6]
• Evaluate the effectiveness of anti-epidemic interventions, pharmaceutical measures, antiviral safety and resistance, vaccine coverage, vaccine efficacy and vaccine safety.[21][29]
• Review recommendations, clinical and laboratory algorithms, intervention plans, communication measures and preparedness plans in response to exercises, real events, epidemiological developments and international guidance.[5][10][31][16]
• Conduct preparedness exercises, including annual communication exercises, and periodically assess capacities, priorities and transmission risks from animal influenza viruses.[7][9][25][33]
• Report national surveillance results regularly to the European Centre for Disease Prevention and Control through The European Surveillance System and to the World Health Organization through FLU-NET.[11]
• Report suspected and laboratory-confirmed human cases through the International Health Regulations and the Early Warning and Response System, while exchanging information with national and international partners.[9][13]
• Maintain oversight through the Central Epidemiology Commission, which evaluates epidemiological developments, reports to the Government, coordinates regional commissions and recommends nationwide anti-epidemic measures.[8]
• Use World Health Organization, European Commission and European Centre for Disease Prevention and Control information-sharing and assessment functions to support pandemic-phase decisions and national action.[3]

The source does not provide a consolidated national indicator set, quantified performance targets, independent evaluation mechanism, sanctions framework or detailed reporting timetable beyond specified surveillance, rapid notification and annual communication-exercise arrangements.[25][33][34]

Costing & Financing

The plan recognises that pandemic preparedness and response require human, material and financial resources for laboratories, healthcare, protective equipment, vaccines, antivirals and continuity of essential services, but it does not provide a quantified implementation budget or costed financing framework.[7][9][34]

• Assess and mobilise the human and financial resources needed for pandemic measures, including laboratory diagnosis and analysis, protective equipment, vaccines and antivirals.[7][9]
• Plan procurement, distribution and use of pre-pandemic and pandemic vaccines, antiviral medicines and personal protective equipment, including for essential-service employees and selected target patient groups.[34][27]
• Maintain state stocks of antivirals and prepare their rapid use, alongside the availability of vaccines and protective equipment.[15][28]
• Apply rational, ethical and transparent procedures for the use of human, material and economic resources, involving health authorities, regions and relevant experts.[28]
• Address anticipated state-budget implications and implement European Commission recommendations on reimbursement of influenza-pandemic costs, with responsibilities assigned to the Government and Ministry of Finance.[26]
• Recognise limited financial and human resources for preparedness and the consequent need for long-term sustainability.[5]
• Assess whether government financial support is required during recovery, including the criteria and means for securing resources, while revising stocks, services and future capacity requirements.[20]

Economic planning anticipates substantial workforce absence from illness, school closures, transport disruption and caring responsibilities.[6]A pandemic assumed to subside after approximately 90 days could reduce annual gross domestic product by 1.5% to 2.0% with effective planning and response, while insufficient planning and an ineffective response could produce a reduction of at least 2.5% to 3.0%.[35]These estimates include absenteeism from illness and care for ill family members but exclude longer-term effects of health damage and deaths.[35]

No currency-denominated budget, total cost, unit cost, funding allocation, identified financing source, quantified funding gap or detailed economic model is specified.[35][7][9]